Annual Interest Expense
$3.18 M
+$651.00 K+25.74%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual interest expense is $3.18 million, with the most recent change of +$651.00 thousand (+25.74%) on December 31, 2023.
- During the last 3 years, PLX annual interest expense has fallen by -$6.49 million (-67.12%).
- PLX annual interest expense is now -67.30% below its all-time high of $9.72 million, reached on December 31, 2017.
Performance
PLX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$299.00 K
-$68.00 K-18.53%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly interest expense is $299.00 thousand, with the most recent change of -$68.00 thousand (-18.53%) on September 30, 2024.
- Over the past year, PLX quarterly interest expense has dropped by -$161.00 thousand (-35.00%).
- PLX quarterly interest expense is now -91.88% below its all-time high of $3.68 million, reached on September 30, 2017.
Performance
PLX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$1.83 M
-$161.00 K-8.09%
September 30, 2024
Summary
- As of February 8, 2025, PLX TTM interest expense is $1.83 million, with the most recent change of -$161.00 thousand (-8.09%) on September 30, 2024.
- Over the past year, PLX TTM interest expense has dropped by -$1.23 million (-40.27%).
- PLX TTM interest expense is now -82.21% below its all-time high of $10.29 million, reached on September 30, 2017.
Performance
PLX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
PLX Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.7% | -35.0% | -40.3% |
| 3 y3 years | -67.1% | -35.0% | -40.3% |
| 5 y5 years | -58.6% | -35.0% | -40.3% |
PLX Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.7% | +25.7% | -77.1% | at low | -76.2% | at low |
| 5 y | 5-year | -67.1% | +25.7% | -90.7% | at low | -81.1% | at low |
| alltime | all time | -67.3% | +9252.9% | -91.9% | -100.0% | -82.2% | -100.0% |
Protalix BioTherapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $299.00 K(-18.5%) | $1.83 M(-8.1%) |
| Jun 2024 | - | $367.00 K(-5.9%) | $1.99 M(-32.0%) |
| Mar 2024 | - | $390.00 K(-49.6%) | $2.93 M(-8.1%) |
| Dec 2023 | $3.18 M(+25.7%) | $774.00 K(+68.3%) | $3.19 M(+4.0%) |
| Sep 2023 | - | $460.00 K(-64.8%) | $3.06 M(-5.5%) |
| Jun 2023 | - | $1.30 M(+101.1%) | $3.24 M(+26.6%) |
| Mar 2023 | - | $649.00 K(-0.2%) | $2.56 M(+1.2%) |
| Dec 2022 | $2.53 M(-66.4%) | $650.00 K(+1.7%) | $2.53 M(-9.3%) |
| Sep 2022 | - | $639.00 K(+2.6%) | $2.79 M(-38.8%) |
| Jun 2022 | - | $623.00 K(+0.8%) | $4.56 M(-25.7%) |
| Mar 2022 | - | $618.00 K(-31.9%) | $6.14 M(-20.0%) |
| Dec 2021 | $7.52 M(-22.2%) | $908.00 K(-62.3%) | $7.68 M(-17.4%) |
| Sep 2021 | - | $2.41 M(+9.4%) | $9.29 M(+4.9%) |
| Jun 2021 | - | $2.20 M(+2.2%) | $8.85 M(+3.0%) |
| Mar 2021 | - | $2.16 M(-14.5%) | $8.60 M(-11.1%) |
| Dec 2020 | $9.67 M(+21.4%) | $2.52 M(+27.8%) | $9.67 M(+4.7%) |
| Sep 2020 | - | $1.97 M(+1.3%) | $9.24 M(-0.8%) |
| Jun 2020 | - | $1.95 M(-39.7%) | $9.32 M(+0.4%) |
| Mar 2020 | - | $3.23 M(+54.6%) | $9.28 M(+16.4%) |
| Dec 2019 | $7.97 M(+3.7%) | $2.09 M(+1.9%) | $7.97 M(+2.9%) |
| Sep 2019 | - | $2.05 M(+7.5%) | $7.74 M(+3.2%) |
| Jun 2019 | - | $1.91 M(-0.7%) | $7.50 M(+1.5%) |
| Mar 2019 | - | $1.92 M(+3.2%) | $7.38 M(-3.9%) |
| Dec 2018 | $7.68 M | $1.86 M(+2.8%) | $7.68 M(+14.0%) |
| Sep 2018 | - | $1.81 M(+1.0%) | $6.74 M(-21.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $1.79 M(-19.2%) | $8.61 M(-12.7%) |
| Mar 2018 | - | $2.22 M(+142.4%) | $9.86 M(+1.4%) |
| Dec 2017 | $9.72 M(+132.0%) | $916.00 K(-75.1%) | $9.73 M(-5.5%) |
| Sep 2017 | - | $3.68 M(+20.9%) | $10.29 M(+36.8%) |
| Jun 2017 | - | $3.04 M(+45.9%) | $7.52 M(+39.9%) |
| Mar 2017 | - | $2.09 M(+41.3%) | $5.38 M(+28.2%) |
| Dec 2016 | $4.19 M(+12.2%) | $1.48 M(+62.3%) | $4.19 M(+15.0%) |
| Sep 2016 | - | $910.00 K(+1.0%) | $3.65 M(-3.2%) |
| Jun 2016 | - | $901.00 K(-0.3%) | $3.77 M(+7.4%) |
| Mar 2016 | - | $904.00 K(-2.8%) | $3.51 M(-6.7%) |
| Dec 2015 | $3.73 M(-24.3%) | $930.00 K(-9.7%) | $3.76 M(-12.0%) |
| Sep 2015 | - | $1.03 M(+60.4%) | $4.27 M(-16.1%) |
| Jun 2015 | - | $642.00 K(-44.5%) | $5.09 M(-4.4%) |
| Mar 2015 | - | $1.16 M(-19.9%) | $5.33 M(+4.8%) |
| Dec 2014 | $4.93 M(+363.4%) | $1.45 M(-21.9%) | $5.08 M(+11.7%) |
| Sep 2014 | - | $1.85 M(+111.8%) | $4.55 M(+60.7%) |
| Jun 2014 | - | $874.00 K(-4.5%) | $2.83 M(+44.0%) |
| Mar 2014 | - | $915.00 K(+0.3%) | $1.97 M(+84.5%) |
| Dec 2013 | $1.06 M(+3032.4%) | $912.00 K(+596.2%) | $1.07 M(+592.2%) |
| Sep 2013 | - | $131.00 K(+1355.6%) | $154.00 K(+569.6%) |
| Jun 2013 | - | $9000.00(-35.7%) | $23.00 K(+64.3%) |
| Mar 2013 | - | $14.00 K(-90.5%) | $14.00 K(-90.5%) |
| Dec 2012 | $34.00 K | - | - |
| Mar 2009 | - | $148.00 K(>+9900.0%) | $148.00 K(>+9900.0%) |
| Mar 2008 | - | $0.00 | $0.00 |
FAQ
- What is Protalix BioTherapeutics annual interest expense?
- What is the all time high annual interest expense for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual interest expense year-on-year change?
- What is Protalix BioTherapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly interest expense year-on-year change?
- What is Protalix BioTherapeutics TTM interest expense?
- What is the all time high TTM interest expense for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics TTM interest expense year-on-year change?
What is Protalix BioTherapeutics annual interest expense?
The current annual interest expense of PLX is $3.18 M
What is the all time high annual interest expense for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual interest expense is $9.72 M
What is Protalix BioTherapeutics annual interest expense year-on-year change?
Over the past year, PLX annual interest expense has changed by +$651.00 K (+25.74%)
What is Protalix BioTherapeutics quarterly interest expense?
The current quarterly interest expense of PLX is $299.00 K
What is the all time high quarterly interest expense for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly interest expense is $3.68 M
What is Protalix BioTherapeutics quarterly interest expense year-on-year change?
Over the past year, PLX quarterly interest expense has changed by -$161.00 K (-35.00%)
What is Protalix BioTherapeutics TTM interest expense?
The current TTM interest expense of PLX is $1.83 M
What is the all time high TTM interest expense for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high TTM interest expense is $10.29 M
What is Protalix BioTherapeutics TTM interest expense year-on-year change?
Over the past year, PLX TTM interest expense has changed by -$1.23 M (-40.27%)